New Key Statistics Module, Z-Score and F-Score
NAS:RCEL Key Ratios
| Market Cap $ M | 263.27 |
| Enterprise Value $ M | 261.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 11.01 |
| Price/Sales | 4.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 54.00 |
| EPS (TTM) $ | -1.95 |
| Beneish M-Score | -3.31 |
| 10-y EBITDA Growth Rate % | 3.80 |
| 5-y EBITDA Growth Rate % | 6.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.69 |
| EV-to-EBITDA | -5.78 |
| PEG | -- |
| Shares Outstanding M | 25.99 |
| Net Margin (%) | -92.04 |
| Operating Margin % | -100.50 |
| Pre-tax Margin (%) | -91.88 |
| Quick Ratio | 4.81 |
| Current Ratio | 5.29 |
| ROA % (ttm) | -53.67 |
| ROE % (ttm) | -105.05 |
| ROIC % (ttm) | -363.02 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.06 |
RCEL Number of Guru Trades
RCEL Volume of Guru Trades
Gurus Latest Trades with NAS:RCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RCEL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AVITA Medical Inc Insider Transactions
No Available Data
News about NAS:RCEL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers